医学
内科学
胃肠病学
血清转化
脂肪变性
脂肪肝
疾病
乙型肝炎
肝病
免疫学
抗体
作者
Shang‐Chin Huang,Tung‐Hung Su,Tai‐Chung Tseng,Chi‐Ling Chen,Shih‐Jer Hsu,Chen‐Hua Liu,Sih‐Han Liao,Chun‐Ming Hong,Ting‐Yuan Lan,Hung‐Chih Yang,Chun‐Jen Liu,Pei‐Jer Chen,Jia‐Horng Kao
标识
DOI:10.1016/j.cgh.2023.09.040
摘要
Hepatitis B surface antigen (HBsAg) seroclearance is the goal of functional cure for hepatitis B virus (HBV) infection. However, the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on this favorable outcome remains unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI